Nordic Capital, a Stockholm, Sweden-based private equity investor, closed Nordic Capital Fund XI funds, at $9 Billion.
Fund XI attracted investors from across the globe, with investors from every continent including 34% from North America, 31% Europe, 23% from Asia, 10% from the Middle East and 1% from RoW. The investor base comprises a well-diversified mix of institutional investors: public and private pension funds (c. 42%); sovereign wealth funds (c. 23%); fund of funds (c. 14%); endowments and family offices (c. 11%) and financial institutions (10%).
The fund will continue to apply deep and specialist experience to its core sectors including Healthcare, Technology & Payments and Financial Services, and selectively, in Industrial & Business Services. Its mandate includes investment in mid to large companies within these sectors in Europe; and within Healthcare and Technology & Payments globally.
Nordic Capital has already enabled the fund to make three investments, including:
- RiskPoint Group, a global independent specialty insurance underwriter based in Copenhagen, with offices in Stockholm, Oslo, Helsinki, Amsterdam, Frankfurt, Zurich, Madrid, London and New York;
- Equashield, a global provider of hazardous drug compounding technologies, with products sold across five continents and the Closed System Drug-Transfer Device (“CSTD”) in the US, and
- the public to private acquisition of Cary Group, a European leader in the repair and replacement of vehicle glass and automotive bodywork.
Nordic Capital is a private equity investor commitment to creating a businesses through operational improvement and transformative growth. Its focus sectors are Healthcare, Technology & Payments, Financial Services, and selectively, Industrial & Business Services. Key regions are Europe and globally for Healthcare and Technology & Payments investments.
FinSMEs
26/10/2022